INS316 in Diagnosing Lung Cancer in Patients With Untreated Lung Cancer

PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

August 31, 2000

Study Completion Date

May 31, 2004

Conditions

Lung Cancer

Interventions

DRUG

INS316

OTHER

sputum cytology

Trial Locations (1)

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00008255 - INS316 in Diagnosing Lung Cancer in Patients With Untreated Lung Cancer | Biotech Hunter | Biotech Hunter